ArticleCardiovascular Effects of Tyrosine Kinase Inhibitors in Patients With Advanced Renal Cell Carcinoma at the VA San Diego Healthcare System (FULL)Author:Angela Yuen, PharmD, BCOPPublish date: May 2, 2020Patients who have or are at high risk for developing cardiovascular disease and who are taking tyrosine kinase inhibitors for renal cell carcinoma ...Read More
